Sunbelt Securities Inc. Grows Position in Sanofi (NASDAQ:SNY)

Sunbelt Securities Inc. lifted its holdings in Sanofi (NASDAQ:SNY) by 72.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 747 shares of the company’s stock after buying an additional 313 shares during the period. Sunbelt Securities Inc.’s holdings in Sanofi were worth $43,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SNY. POM Investment Strategies LLC purchased a new position in Sanofi in the 2nd quarter worth approximately $25,000. Northwest Investment Counselors LLC purchased a new stake in shares of Sanofi in the third quarter valued at approximately $29,000. Concord Wealth Partners increased its holdings in shares of Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after purchasing an additional 363 shares during the last quarter. Arrow Financial Corp acquired a new position in Sanofi during the second quarter worth $35,000. Finally, Fortitude Family Office LLC grew its holdings in Sanofi by 708.6% in the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after buying an additional 659 shares in the last quarter. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently commented on SNY. Citigroup upgraded Sanofi to a “strong-buy” rating in a report on Tuesday, September 17th. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $57.50.

Sanofi Stock Down 0.4 %

Shares of NASDAQ SNY opened at $46.80 on Monday. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average is $51.02 and its two-hundred day moving average is $52.10. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97. The firm has a market cap of $118.77 billion, a price-to-earnings ratio of 23.88, a PEG ratio of 1.23 and a beta of 0.58.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The business had revenue of $13.44 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same period in the previous year, the firm posted $2.55 earnings per share. The company’s revenue was up 12.3% on a year-over-year basis. Research analysts predict that Sanofi will post 4.06 EPS for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.